637 - 648 of 7601 results

Early Recognition of axSpA in Primary Care Chapter 2: Key features of axSpA

Industry Webcast Sponsored by Novartis Pharmaceutical, LLC; Not for CME/CE Credit

View this presentation to learn more about the important role of primary care providers in the early recognition of axSpA. This presentation is the second chapter of a series of videos exploring axSpA.


Join Dr. Ty Gluckman as he dives deeper into the treatment of atrial fibrillation. This program will focus on rate and rhythm control and the pivotal role they play in alleviating symptoms of AF. Dr. Gluckman will discuss factors that would guide clinical decision making towards a strategy that focuses on rate vs rhythm control.


In the nineteenth episode of Pri-Med’s web series on COVID-19, faculty will explore recent reports of subclinical myocarditis among those that have recovered from COVID-19. Faculty will also discuss how, as we move into flu season, we can understand the differences in COVID-19 and influenza when it comes to symptoms and outcomes in both the adult and pediatric populations.

Primary Care Pulse: Live on November 17, 2020

Pri-Med's new weekly CME/CE web series, Primary Care Pulse, features live conversations about timely topics and concerns facing primary care clinicians.


This session will review a number of clinically relevant trials/topics recently presented at the American College of Cardiology Scientific Sessions in March 2018, including updates in the management of patients with hypercholesterolemia, heart failure, valvular heart disease, arrhythmias, and more.


In the last year, two new diseases have emerged with significant and lasting impact on the lung: E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and COVID-19 pneumonia. This session will address new information and challenges related to both diseases. Vaping has increased in popularity, especially among youth, and in late 2019, EVALI was first described. While the outbreak has subsided, recognition of the symptoms, association with marijuana use, and radiographic findings of EVALI remain important. Further, providing tobacco and marijuana cessation guidance remains critical. The COVID-19 pandemic, caused by SARS-Cov2 virus, has burdened healthcare workers and scientists across the globe. COVID-19, often associated with severe pneumonia and systemic illness, has resulted in significant morbidity and mortality in the US and we can continue to learn and discover its full impact. Additionally, COVID-19 has unmasked major health disparities in our healthcare system that we must address.


This session will use four case presentations as a guide to review cancer and chronic disease differences and prevalence by race/ethnicity. Specific differences in diseases seen in Asian Americans and African Americans will be highlighted. Tobacco use and trends in different populations will also be emphasized.


During this informative session on medical literature updates (excluding COVID-19), primary care physician, Dr. Charles Vega, will review the clinical implications of practice-changing literature that has been recently published. Topics for discussion will include: breast cancer screening, colorectal cancer screening, association between diet/exercise and cancer, vaccination updates, dietary coconut oil, milk preference in children, personal protective equipment, COPD management, deprescribing in older adults, metformin in chronic kidney disease, and medication assisted treatment for opioid use disorder. You don’t want to miss these updates!


Thyroid: "Curbsiders"

1.00 CME/MOC
1.00 AANP | 0.40 Pharmacology


Migraine is one of the leading causes of pain and disability worldwide, but initiation of effective treatment is often delayed by misdiagnosis and unnecessary testing. This focused session aims to improve your confidence in the clinical diagnosis of migraine. Primary care physician Dr. Susan Burke, and headache specialist Dr. Katherine Carroll, discuss the differential diagnosis of headache and review how to clinically diagnose migraine. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 7/31/2020 and they are subject to change as new information is published.

This session on influenza diagnosis and management will improve how you respond when annual fluctuations in vaccine efficacy expose your patients to risk of serious illness. Through interactive patient cases, the faculty will demonstrate how to identify and treat patients with suspected influenza, including patients at high risk for complications. These practical, evidence-based strategies will help you to use antiviral medications effectively and reduce the burden of influenza.